Literature DB >> 23499148

Prevention of osteonecrosis of the jaw by mucoperiosteal coverage in a rat model.

J Abtahi1, F Agholme, P Aspenberg.   

Abstract

There is evidence for a link between the use of systemic bisphosphonates and osteonecrosis of the jaw (ONJ). This condition has the appearance of chronic osteomyelitis, and antibiotics prevent the development of ONJ in animal models. Clinically, ONJ can sometimes be treated successfully by mucoperiosteal coverage. If ONJ is indeed primarily caused by bacterial infection, immediate coverage of the extraction alveolus might reduce the risk of ONJ developing in risk patients. Therefore, we studied whether immediate mucoperiosteal coverage after tooth extraction could prevent the development of ONJ in a rat model. Thirty rats were randomly allocated to three groups (10 in each): (1) group I (controls): extraction, no drug treatment; (2) group II (non-coverage): extraction, dexamethasone plus alendronate; (3) group III (coverage): extraction, dexamethasone plus alendronate, plus coverage with a mucoperiosteal flap. Rats were examined for macroscopic ONJ-like wounds after 2 weeks. All animals in the non-coverage group developed large ONJ-like changes. The coverage and control groups showed an intact overlying mucosa in all rats. Findings were confirmed with histology. Bisphosphonates and dexamethasone caused ONJ-like lesions after tooth extraction in a rat model. This was prevented by immediate mucoperiosteal coverage. The risk of ONJ in patients using bisphosphonates might be reduced by mucoperiosteal coverage after tooth extraction.
Copyright © 2013 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23499148     DOI: 10.1016/j.ijom.2013.02.007

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  15 in total

Review 1.  Osteonecrosis of the Jaw-a Bone Site-Specific Effect of Bisphosphonates.

Authors:  Jenny A F Vermeer; Greetje A P Renders; Vincent Everts
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

2.  The effect of laser therapy on the expression of osteocalcin and osteopontin after tooth extraction in rats treated with zoledronate and dexamethasone.

Authors:  Giovanni Mergoni; Paolo Vescovi; Roberto Sala; Elisabetta Merigo; Pietro Passerini; Roberta Maestri; Domenico Corradi; Paolo Govoni; Samir Nammour; Massimiliano G Bianchi
Journal:  Support Care Cancer       Date:  2015-07-21       Impact factor: 3.603

3.  Bone mineralization and vascularization in bisphosphonate-related osteonecrosis of the jaw: an experimental study in the rat.

Authors:  Jean-Daniel Kün-Darbois; Hélène Libouban; Guillaume Mabilleau; Florence Pascaretti-Grizon; Daniel Chappard
Journal:  Clin Oral Investig       Date:  2018-02-16       Impact factor: 3.573

Review 4.  Preclinical models of medication-related osteonecrosis of the jaw (MRONJ).

Authors:  J I Aguirre; E J Castillo; D B Kimmel
Journal:  Bone       Date:  2021-09-11       Impact factor: 4.398

5.  A Model for Osteonecrosis of the Jaw with Zoledronate Treatment following Repeated Major Trauma.

Authors:  R Nicole Howie; James L Borke; Zoya Kurago; Asma Daoudi; James Cray; Ibrahim E Zakhary; Tara L Brown; J Nathan Raley; Loan T Tran; Regina Messer; Fardous Medani; Mohammed E Elsalanty
Journal:  PLoS One       Date:  2015-07-17       Impact factor: 3.240

Review 6.  Bisphosphonate associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment.

Authors:  Lars Rasmusson; Jahan Abtahi
Journal:  Int J Dent       Date:  2014-09-01

Review 7.  Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).

Authors:  Sven Otto; Suad Aljohani; Riham Fliefel; Sara Ecke; Oliver Ristow; Egon Burian; Matthias Troeltzsch; Christoph Pautke; Michael Ehrenfeld
Journal:  Medicina (Kaunas)       Date:  2021-05-09       Impact factor: 2.430

8.  Bisphosphonate associated osteomyelitis of the jaw in patients with bony exposure: prevention, a new way of thinking.

Authors:  Arezo Tardast; Reine Sjöman; Sigbjørn Løes; Jahan Abtahi
Journal:  J Appl Oral Sci       Date:  2015 May-Jun       Impact factor: 2.698

9.  Early effects of parathyroid hormone on bisphosphonate/steroid-associated compromised osseous wound healing.

Authors:  S Kuroshima; P Entezami; L K McCauley; J Yamashita
Journal:  Osteoporos Int       Date:  2013-12-04       Impact factor: 4.507

10.  Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw.

Authors:  Siri Paulo; Mafalda Laranjo; Anabela Paula; Ana Margarida Abrantes; João Martins; Carlos Miguel Marto; Ana Coelho; João Casalta-Lopes; Lina Carvalho; Eunice Carrilho; Arménio Serra; Maria Filomena Botelho; Manuel Marques Ferreira
Journal:  Materials (Basel)       Date:  2020-04-22       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.